60 The survey data have some limitations. Two of the larger surveys had an international focus, 1 involving face-to-face interviews with patients referred by their oncologists in both developed and developing countries. Otherwise, the 13 surveys may not have captured data representative of the entire MBC population. First, all but 1 survey was completed online. Consequently, the demographic information collected reflects Internet users, who tend to be affluent, educated, and white[116] —and data from population-based registries show that poor and black patients have worse breast cancer outcomes[30] . And because these surveys were promoted in online patient MBC communities, it is likely that some motivated patients responded to more than 1 survey. Finally, overall, the survey respondents had a mean age of 55 years (younger than the median age of invasive breast cancer diagnosis in the US, 61 years)[30] , were well educated, had health insurance, were married or partnered, and were predominantly white, and nearly half had children still living at home. Not available for review and analysis are the upcoming results from the Novartis Oncology “Make Your Dialogue Count” survey in the US, conducted during the summer of 2014. This survey included 234 caregivers, along with 359 women living with MBC and 252 licensed oncologists to better understand potential gaps in treatment goals among patients and oncologists, experiences dealing with treatment side effects, and related emotional dynamics. Survey responses will be reported in December 2014 at the San Antonio Breast Cancer Symposium.